Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Projections for the CAGR of the Wearable Injectors Market Size From 2025 to 2034?

In recent times, there has been a swift expansion of the wearable injectors market. Expected to scale from $8.84 billion in 2024 to $9.84 billion in 2025, the market boasts a compound annual growth rate (CAGR) of 11.3%. Factors such as management of chronic diseases, patient comfort, technological progress, and the increase in the elderly population have contributed to the growth experienced in the historic period.

The market for wearable injectors is projected to experience a swift expansion in the coming years, reaching a worth of $17.2 billion by 2029 with a 15.0% compound annual growth rate (CAGR). The predicted growth for the forecast period is primarily due to factors such as individualized medicine, monitoring patients remotely, drug development, and management of chronic diseases. Leading trends for the forecast period are expected to include biologics and large molecules, dual-chamber wearables, intelligently connected devices, and patch pump technology.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3308&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Wearable Injectors Market?

The rise in chronic diseases such as cardiovascular disease, diabetes, and cancer has significantly propelled the growth of the wearable injector market. A clear example of this is reflected in a report from April 2023 by the British Diabetic Association, a UK-based charity for individuals suffering from diabetes. The report revealed that about 4.3 million people in the UK have been diagnosed with diabetes. Of this number, nearly 90% have type 2 diabetes, with around 8% being diagnosed with type 1 diabetes and the remaining 2% having other types of diabetes. This dramatic rise in numbers of people with diabetes and other chronic illnesses has led to an increase demand for treatments, consequently boosting the expansion of the wearable injectors market.

Which Key Market Segments Comprise the Wearable Injectors Market and Drive Its Revenue Growth?

The wearable injectorsmarket covered in this report is segmented –

1) By Type: On-Body Injectors, Off-Body Injectors

2) By End-User: Hospitals, Clinics, Homecare setting

3) By Application: Immuno-Oncology, Diabetes, Cardiovascular Diseases, Other Applications

Subsegments:

1) By On-Body Injectors: Patch-Based Injectors, Adhesive-Based Injectors, Needle-Based Injectors, Needle-Free Injectors

2) By Off-Body Injectors: Belt-Based Injectors, Handheld Injectors, Clip-Based Injectors

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=3308&type=smp

Which Areas Are Leading Regions in the Wearable Injectors Market Expansion Across the Globe?

North America was the largest region in the wearable injectors market in 2024. Western Europe was the second-largest region in the wearable injectors market analysis. The regions covered in the wearable injectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Key Market Trends in theWearable Injectors Market Over the Coming Years?

The wearable injectors manufacturing sector sees a multitude of businesses pivoting towards innovating advanced products, such as the on-body injector (OBI). These technological developments address the increasing demand for self-administration of biologics, enhancing patient comfort and adherence to therapy regimens. An OBI is a technically advanced drug delivery device worn by the patient, designed to dispense medication subcutaneously within a designated time frame. This device is especially beneficial to patients requiring injections with large volumes or at specified times. For example, Udenyca, an advanced drug delivery device using the LTS Sorrel wearable platform, was launched by the US biotech firm Coherus BioSciences Inc. in February 2024. Specifically, Udenyca was developed for the administration of pegfilgrastim-cbqv, a biosimilar pegfilgrastim, utilised post-chemotherapy to reduce the chances of developing febrile neutropenia – a condition marked by fever and a decreased number of white blood cells, often resulting from infections. The OBI ensures exact medication dosing for patients, providing the ease of at-home administration, which negates the need for extra clinic visits.

View the full report here:

https://www.thebusinessresearchcompany.com/report/wearable-injectors-global-market-report

How Is the Wearable Injectors Market Conceptually Defined?

Wearable injectors are drug delivery devices that adhere to the body while the drug is administered subcutaneously over a preset time period.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3308

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model